These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27555627)

  • 1. Comment on Podmore et al. Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study. Diabetes Care 2016;39:572-581.
    Mascitelli L; Goldstein MR; Zacharski LR
    Diabetes Care; 2016 Sep; 39(9):e149-50. PubMed ID: 27555627
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
    Mazzucchelli C; Bordone C; Maggi D; Cordera R
    Diabetes Care; 2015 Aug; 38(8):e125-6. PubMed ID: 26207066
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
    Landman GW; Kleefstra N; Houweling ST
    Diabetes Care; 2015 Aug; 38(8):e127. PubMed ID: 26207067
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
    McCormack JP; Martin SA; Newman DH
    Diabetes Care; 2015 Sep; 38(9):e141-2. PubMed ID: 26294778
    [No Abstract]   [Full Text] [Related]  

  • 5. Response to Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
    Herman WH
    Diabetes Care; 2015 Sep; 38(9):e143. PubMed ID: 26294779
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
    Inzucchi SE; Matthews DR;
    Diabetes Care; 2015 Aug; 38(8):e128-9. PubMed ID: 26207068
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122.
    Ceriello A; Genovese S; Mannucci E; Gronda E
    Diabetes Care; 2016 Nov; 39(11):e195. PubMed ID: 27926895
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on: Raz et al. Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum. Diabetes care 2013;36:1779-1788.
    Giugliano D; Esposito K
    Diabetes Care; 2013 Nov; 36(11):e192. PubMed ID: 24159187
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201.
    Garvey WT
    Diabetes Care; 2017 Feb; 40(2):e21-e22. PubMed ID: 28108539
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201.
    Cefalu WT; Buse JB; Tuomilehto J; Fleming GA; Ferrannini E; Gerstein HC; Bennett PH; Ramachandran A; Raz I; Rosenstock J; Kahn SE
    Diabetes Care; 2017 Feb; 40(2):e23-e24. PubMed ID: 28108540
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on Riddle et al.
    Hall LL; Puckrein GA; Davidson JA
    Diabetes Care; 2019 Nov; 42(11):e183. PubMed ID: 31636150
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721.
    Cerasi E
    Diabetologia; 2007 Mar; 50(3):693-4. PubMed ID: 17187245
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to Comment on Riddle et al.
    Riddle MC; Cefalu WT; Gregg EW
    Diabetes Care; 2019 Nov; 42(11):e184. PubMed ID: 31636151
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721.
    Cryer PE
    Diabetologia; 2007 Jan; 50(1):222-4; discussion 225-30; author reply 231-3. PubMed ID: 17047916
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on Rubino et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care 2016;39:861-877.
    Ramos-Leví AM; Rubio MA
    Diabetes Care; 2017 Jul; 40(7):e90-e91. PubMed ID: 28637891
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on Rubino et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care 2016;39:861-877.
    Aberle J; Göke B
    Diabetes Care; 2016 Nov; 39(11):e201. PubMed ID: 27926899
    [No Abstract]   [Full Text] [Related]  

  • 17. Response to Comment on Rubino et al. Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care 2016;39:861-877.
    Cummings DE; Rubino F
    Diabetes Care; 2016 Nov; 39(11):e202-e203. PubMed ID: 27926900
    [No Abstract]   [Full Text] [Related]  

  • 18. Comment on Jakubowicz et al. Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2015;38:1820-1826.
    Ganda OP
    Diabetes Care; 2016 Feb; 39(2):e28. PubMed ID: 26798157
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
    Vigneri R; Sava L; Squatrito S; Sciacca L
    Diabetes; 2010 Nov; 59(11):e24. PubMed ID: 20980466
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes;59:1254-1260.
    Simon D; Balkau B
    Diabetes; 2010 Nov; 59(11):e25. PubMed ID: 20980467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.